Daniel D. Long, SVP, Drug Discovery at Septerna, Inc. (SEPN), sold 3,333 shares at $34.10 ($115K) on 2026-07-01, disclosed to the SEC on 2026-07-02.
Scheduled sale ($115k) by SVP, Drug Discovery under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.10 | 2,100 | $72K | 62.5% |
| 2 | $34.81 | 1,233 | $43K | 37.5% |
| Total | $34.36 avg | 3,333 | $115K | 100% |
| Filing → |
| SEPN | SELL | 2026-06-24 | $533K | — | Filing → |
| SEPN | SELL | 2025-11-13 | $126K | — | Filing → |